Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bodhi Tree Biotechnology (BDTB) EBT Margin (2024 - 2025)

Historic EBT Margin for Bodhi Tree Biotechnology (BDTB) over the last 2 years, with Q3 2025 value amounting to 89.06%.

  • Bodhi Tree Biotechnology's EBT Margin changed N/A to 89.06% in Q3 2025 from the same period last year, while for Dec 2025 it was 1131.56%, marking a year-over-year change of. This contributed to the annual value of 868.33% for FY2025, which is N/A changed from last year.
  • As of Q3 2025, Bodhi Tree Biotechnology's EBT Margin stood at 89.06%.
  • Bodhi Tree Biotechnology's 5-year EBT Margin high stood at 89.06% for Q3 2025, and its period low was 1295.54% during Q4 2024.